Schatzbergs Manual of Clinical Psychopharmacology (10)

A seminal resource since the first edition was published in 1986, Schatzbergs Manual of Clinical Psychopharmacology has distinguished itself, from the very beginning, for its readability and comprehensive approach to the field. This tenth edition builds on that legacy, providing a thorough understanding of evolving treatments and medications. Blending evidencebased information with practical, realworld experience, this accessible volume examines the efficacy, dosing, and side effects of drug classes such as antidepressants, antipsychotic medications, mood stabilizers, and stimulants. Key features of this edition include the following: Updated information on newly FDAapproved agents such as vesicular monoamine transporter type2 inhibitors for tardive dyskinesia, as well as those in latestage review A new chapter on pharmacogenomic testing and other commercially available tests designed to help clinicians select appropriate medications for their patients Quickreference summary tables on psychotropic classes for swift access to essential information, facilitating informed decisionmaking in clinical practice A comprehensive list of suggested readings for each chapter, opening the door to further study and explorationAdditional sections also discuss approaches to treatmentresistant disorders, pharmacotherapy for substance use disorders, and working in specific settings and with special populationsincluding emergency department treatment and treating pregnant patients, children, and individuals from minority and marginalized communities. With its unrivaled wealth of information, Schatzbergs Manual of Clinical Psychopharmacology remains a trusted, indispensable resource for clinicians seeking the latest advancements in psychopharmacology, arming them with the knowledge they will need to navigate with confidence the intricacies of psychotropic medications.